Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy-Reference-Cited by-同舟云学术

Acute Hepatitis C Virus Infection Treated with Daclatasvir/Sofosbuvir in a 9-Year-Old Boy

Published:2022-01 Issue:01 Volume:12 Page:e79-e82
ISSN:2474-5871
Container-title:Journal of Child Science
language:en
Short-container-title:Journal of Child Science

Author:

Rahmani Parisa¹^ORCID,Farahmand Fatemeh²,Heidari Ghobad³

Affiliation:

1. Pediatric Gastroenterology and Hepatology Research Center, Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

2. Department of Pediatric Gastroenterology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Pediatric, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

Abstract

AbstractThe present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy were positive for hepatitis C virus. He was treated with daclatasvir/sofosbuvir for 3 months. Daclatasvir/sofosbuvir might be effective against the treatment of hepatitis in children, with no report of remission and minimal side effects.

Publisher

Georg Thieme Verlag KG

Subject

Pediatrics, Perinatology and Child Health,Surgery

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1751269.pdf

Reference15 articles.

1. Hepatitis C virus infection in children and adolescents;J E Squires;Hepatol Commun,2017

2. The epidemiology of hepatitis C virus in Iran: systematic review and meta-analyses;S Mahmud;Sci Rep,2018

3. Profound jaundice in a patient with acute hepatitis C;P Lohia;BMJ Case Rep,2013

4. Overview of direct-acting antiviral drugs and drug resistance of hepatitis C virus;D K Li;Methods Mol Biol,2019

5. Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus recommendations;M Lagging;Infect Dis (Lond),2016